AIC
SCPH

AWM Investment Company’s scPharmaceuticals SCPH Stock Holding History

AWM Investment Company’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-764,857
Closed -$3.49M – 97
2024
Q3 		$3.49M Buy
+764,857
New +$3.7M 0.42% 59
2019
Q2 		– Sell
-246,057
Closed -$738K – 93
2019
Q1 		$738K Sell
246,057
-167,447
-40% -$575K 0.15% 74
2018
Q4 		$1.55M Sell
413,504
-56,295
-12% -$265K 0.34% 67
2018
Q3 		$2.76M Buy
469,799
+63,992
+16% +$326K 0.46% 62
2018
Q2 		$2.3M Buy
405,807
+192,490
+90% +$1.98M 0.38% 65
2018
Q1 		$2.65M Buy
213,317
+48,217
+29% +$648K 0.51% 55
2017
Q4 		$2M Buy
+165,100
New +$2.33M 0.39% 65

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

AWM Investment Company's SCPH Position: Q4 2024 in Review

AWM Investment Company sold out of scPharmaceuticals (SCPH) in Q4 2024, closing a stake of 764,857 shares — an estimated $3.49M sold.

AWM Investment Company first reported a position in SCPH in Q4 2017 and held it in 7 quarters. The position peaked at $3.49M in Q3 2024. 85 funds tracked by Wall St. Rank hold SCPH as of Q4 2024.

  • AWM Investment Company reported no remaining scPharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • AWM Investment Company sold 764,857 scPharmaceuticals shares in Q4 2024, an estimated $3.49M.
  • AWM Investment Company first reported a position in scPharmaceuticals in Q4 2017 and held it in 7 quarters.
  • AWM Investment Company's scPharmaceuticals position peaked at $3.49M in Q3 2024.
  • 85 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2024.

Based on AWM Investment Company's 13F filing for Q4 2024, filed 18 Feb 2025.